DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» BRD2
BRD2
Function of Bromodomain and Extra-Terminal Motif Proteins (Bets) in Gata1-Mediated Transcription
Bromodomain Protein BRDT Directs ΔNp63 Function and Super
Reviews
Download Product Insert (PDF)
Epigenetic Reader BRD4 Inhibition As a Therapeutic Strategy to Suppress E2F2-Cell Cycle Regulation Circuit in Liver Cancer
BRD2-2 (His) (Bromodomain Containing Protein 2 (RING3), Bromodomain 2)
BRD2 Bromodomains 1 and 2 TR-FRET Assay Kit
BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-To-Mesenchymal Transition
BRD2 (RING3) Is a Probable Major Susceptibility Gene for Common Juvenile Myoclonic Epilepsy Deb K
Spatially Restricted Loading of BRD2 at DNA Double-Strand Breaks Protects
Cyclic Peptides Can Engage a Single Binding Pocket Through Highly Divergent Modes
Integrated Analyses of a Major Histocompatibility Complex, Methylation and Transcribed Ultra-Conserved Regions in Systemic Lupus Erythematosus
The Genetic and Biochemical Analysis of the Chromatin- Targeting Protein BRD2 in Mammalian Development
Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
Recombinant BRD3 (24-144) Protein Catalog No: 31379, 31779 Quantity: 100, 1000 Μg Lot No: 32717003 Concentration: 1.8 Μg/Μl Expressed In: E
Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation
Relevance of BET Family Proteins in SARS-Cov-2 Infection
Bromodomain-Containing Protein BRPF1 Is a Therapeutic Target for Liver Cancer
Top View
BRD2 Regulation of Sigma-2 Receptor Expression Upon Cytosolic Cholesterol Deprivation
Bromodomain Protein Brd3 Associates with Acetylated GATA1 to Promote
Distinct Roles for BET Family Members in Estrogen Receptor a Enhancer Function and Gene Regulation in Breast Cancer Cells
BET Bromodomains Regulate Neurobehavioral Responses to Psychostimulants Gregory C. Sartor and Claes Wahlestedt Center for Therap
Inhibition of BET Bromodomains As a Therapeutic Strategy for Cancer Drug Discovery
Discovery and Characterization of Bromodomain 2–Specific Inhibitors of BRDT
BRD3 Full-Length (His) (Bromodomain Containing Protein 3 (RING3L))
Are BET Inhibitors Yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
BRD3-2 (GST) (Bromodomain Containing Protein 3 (RING3L), Bromodomain 2)
Targetable BET Proteins- and E2F1-Dependent Transcriptional Program Maintains the Malignancy of Glioblastoma
An Epigenetic Screening Determines BET Proteins As Targets to Suppress Self-Renewal and Tumorigenicity in Canine Mammary Cancer Cells Pedro L
Download Product Insert (PDF)
Regulation of Major Histocompatibility Complex Class II Gene Expression, Genetic Variation and Disease
GATA-1-Dependent Histone H3k27ac Mediates Erythroid Cell-Specific Interaction Between CTCF Sites
Chromatin Targeting Drugs in Cancer and Immunity
Recombinant BRD2 (71-194) Protein Catalog No: 31442, 31842 Quantity: 100, 1000 Μg Expressed In: E
The HLA Genomic Loci Map: Expression, Interaction, Diversity and Disease
The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins